Status:
UNKNOWN
Monitoring Response to Antiplatelet Therapy
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
Coronary Stenosis
Coronary Thrombosis
Eligibility:
All Genders
18-80 years
Brief Summary
Antiplatelet therapy plays a key role in the prevention of complications related to coronary angioplasty and stenting (PCI) including procedure related myocardial damage. Aspirin and clopidogrel are n...
Eligibility Criteria
Inclusion
- Patients aged 18-80 undergoing intended PCI for conventional indications. Informed written consent.
Exclusion
- Administration of GPIIbIIIa therapy prior to PCI, Oral anticoagulation, ticlopidine, dipyridamole, NSAID therapy, Pregnancy, Troponin I \>0.2mcg/l on day of procedure, Chest pain in the 24 hrs prior to PCI. Anaemia (Hb\<10g/dl). Platelet Count \<150 or \>450 x10\^9/l, Personal or family history of bleeding disorder.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
September 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00327041
Start Date
January 1 2006
End Date
September 1 2006
Last Update
May 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Infirmary
Glasgow, Scotland, United Kingdom, G11 6NT